Pfaar, OKlimek, LJutel, MAkdis, CABousquet, JBreiteneder, HChinthrajah, SDiamant, ZEiwegger, TFokkens, WJFritsch, HWNadeau, KCO'Hehir, REO'Mahony, LRief, WSampath, VSchedlowski, MTorres, MJTraidl-Hoffmann, CWang, YZhang, LBonini, MBrehler, RBrough, HAChivato, TDel Giacco, SRDramburg, SGawlik, RGelincik, AHoffmann-Sommergruber, KHox, VKnol, EFLauerma, AMatricardi, PMMortz, CGOllert, MPalomares, ORiggioni, CSchwarze, JSkypala, IUntersmayr, EWalusiak-Skorupa, JAnsotegui, IJBachert, CBedbrook, ABosnic-Anticevich, SBrussino, LCanonica, GWCardona, VCarreiro-Martins, PCruz, AACzarlewski, WFonseca, JAGotua, MHaahtela, TIvancevich, JCKuna, PKvedariene, VLarenas-Linnemann, DEAbdul Latiff, AHMäkelä, MMorais-Almeida, MMullol, JNaclerio, ROhta, KOkamoto, YOnorato, GLPapadopoulos, NGPatella, VRegateiro, FSSamoliński, BSuppli Ulrik, CToppila-Salmi, SValiulis, AVentura, MTYorgancioglu, AZuberbier, TAgache, I2021-04-152021-04-152021Allergy . 2021 Mar;76(3):648-676http://hdl.handle.net/10400.17/3663The coronavirus disease 2019 (COVID-19) has evolved into a pandemic infectious disease transmitted by the severe acute respiratory syndrome coronavirus (SARS-CoV-2). Allergists and other healthcare providers (HCPs) in the field of allergies and associated airway diseases are on the front line, taking care of patients potentially infected with SARS-CoV-2. Hence, strategies and practices to minimize risks of infection for both HCPs and treated patients have to be developed and followed by allergy clinics.engAllergistsCOVID-19Health PersonnelHumansHypersensitivityInformation TechnologyPatient Care TeamTriageSARS-CoV-2HDE ALERjournal article10.1111/all.14453